Ann: FDA Breakthrough Device Designation, page-74

i hold both IBX and BD1.. These are both looking very promising.. i actually thought bd1 would have made a run much bigger than IBX by now. BD1 are still at around .03 and have developed and proven a non intrusive overian and lung cancer test patented wordwide which has just been tested and proven by Thermal Fisher Scientific and now moving into the commercialisation faze, financially strong with over 10 mil in the account. looking forward to some good movement in both IBX and BD1 which is also on the verge of skyrocketing.